- Report
- July 2022
- 60 Pages
Global
From €600EUR$669USD£518GBP
- Report
- June 2022
- 115 Pages
Global
From €1050EUR$1,171USD£907GBP
- Report
- June 2024
- 240 Pages
Global
From €490EUR$510USD£409GBP
- Report
- August 2024
- 660 Pages
Brazil
From €3169EUR$3,300USD£2,645GBP
- Report
- July 2024
- 500 Pages
Turkey
From €3169EUR$3,300USD£2,645GBP
- Report
- October 2023
- 420 Pages
Global
From €2785EUR$2,900USD£2,325GBP
- Drug Pipelines
- August 2023
- 400 Pages
China
From €2881EUR$3,000USD£2,405GBP
- Drug Pipelines
- August 2023
- 580 Pages
United States
From €4033EUR$4,200USD£3,367GBP
- Report
- June 2023
- 600 Pages
Global
From €3457EUR$3,600USD£2,886GBP
- Report
- March 2023
- 300 Pages
Global
From €2689EUR$2,800USD£2,244GBP
- Report
- January 2023
- 150 Pages
Global
From €2305EUR$2,400USD£1,924GBP
- Report
- September 2022
- 300 Pages
China
From €2881EUR$3,000USD£2,405GBP
- Report
- August 2022
- 600 Pages
Global
From €2881EUR$3,000USD£2,405GBP
- Report
- July 2022
- 2190 Pages
Global
From €3457EUR$3,600USD£2,886GBP
- Report
- June 2022
- 1500 Pages
Global
From €3745EUR$3,900USD£3,126GBP
- Report
- May 2022
- 330 Pages
Global
From €2881EUR$3,000USD£2,405GBP
- Report
- May 2022
- 510 Pages
Global
From €2881EUR$3,000USD£2,405GBP
- Drug Pipelines
- May 2022
- 400 Pages
Global
From €2881EUR$3,000USD£2,405GBP
- Report
- May 2022
- 240 Pages
Global
From €3169EUR$3,300USD£2,645GBP
- Drug Pipelines
- March 2022
- 900 Pages
Global
From €8643EUR$9,000USD£7,214GBP
The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy.
The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more